About Minerva Surgical
Minerva Surgical is a company based in Redwood City (United States) founded in 2008. It operates as a Direct-to-Consumer (D2C) and Professional Services. Minerva Surgical has raised $135.1 million across 16 funding rounds from investors including Accelmed and NEA. The company has 155 employees as of December 31, 2022. Minerva Surgical offers products and services including Minerva EAS, Symphion, Genesys HTA, Resectr, and HERizon. Minerva Surgical operates in a competitive market with competitors including Gynesonics, Channel Medsystems, LUMINELLE, Interlace Medical and Endosee, among others.
- Headquarter Redwood City, United States
- Employees 155 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Minerva Surgical, Inc.
-
Annual Revenue
$50.29 M (USD)-3.47as on Dec 31, 2022
-
Net Profit
-$34.11 M (USD)-58.93as on Dec 31, 2022
-
EBITDA
-$28.56 M (USD)-57.82as on Dec 31, 2022
-
Total Equity Funding
$135.1 M (USD)
in 16 rounds
-
Latest Funding Round
Not available
-
Investors
Accelmed
& 1 more
-
Employee Count
155
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Minerva Surgical
Minerva Surgical is a publicly listed company on the OTC with ticker symbol UTRS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Minerva Surgical
Minerva Surgical offers a comprehensive portfolio of products and services, including Minerva EAS, Symphion, Genesys HTA, Resectr, and HERizon.
Endometrial ablation system using multiple tissue ablation methods.
Operative hysteroscopy system for fibroid and polyp removal.
Endometrial ablation device with continuous direct visualization feature.
Tissue resection device designed for ease and control.
Disposable hysteroscopy system for in-office diagnostic evaluation.
People of Minerva Surgical
Unlock access to complete
Unlock access to complete
Funding Insights of Minerva Surgical
Minerva Surgical has successfully raised a total of $135.1M across 16 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Minerva Surgical
Minerva Surgical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Accelmed and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked |
Investor details for Minerva Surgical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Minerva Surgical
Investment portfolio details for Minerva Surgical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Minerva Surgical
Detailed financials for Minerva Surgical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Minerva Surgical Comparisons
Peer comparison for Minerva Surgical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Minerva Surgical
Minerva Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gynesonics, Channel Medsystems, LUMINELLE, Interlace Medical and Endosee, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A minimally invasive ablation system for uterine fibroids is developed.
|
|
| Locked | Locked | Locked |
Cryothermic technology for endometrial ablation to control heavy bleeding
|
|
| Locked | Locked | Locked |
Hysteroscopy system is developed for minimally invasive endometrial procedures.
|
|
| Locked | Locked | Locked |
Gynecological devices for office-based procedures are designed and developed.
|
|
| Locked | Locked | Locked |
Disposable office-based hysteroscopy systems are developed for gynecological procedures.
|
Detailed competitors of Minerva Surgical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Minerva Surgical
Complete news archive for Minerva Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Minerva Surgical
Minerva Surgical was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Minerva Surgical is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
David Clapper is the current CEO of Minerva Surgical.
Minerva Surgical is a funded company, having raised a total of $135.1M across 16 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Minerva Surgical is 155.
Annual revenue of Minerva Surgical is $50.29M as on Dec 31, 2022.
Minerva Surgical, Inc. is dedicated to advancing womens uterine health through innovative medical devices. The company specializes in minimally invasive intrauterine treatments for Abnormal Uterine Bleeding (AUB), offering a comprehensive suite of products designed for safety, efficiency, and effectiveness. Solutions are provided for both normal and irregular-shaped uteri, addressing root causes with technologies like endometrial ablation and hysteroscopy systems. Support, training, and education are extended to healthcare professionals across various settings, including hospitals and private practices. The focus remains on gynecologic surgery advancements within the healthcare sector.
Minerva Surgical's top competitors include Gynesonics, Channel Medsystems and LUMINELLE.
Minerva Surgical offers Minerva EAS, Symphion, Genesys HTA, Resectr, and HERizon.
Yes, Minerva Surgical is publicly traded on OTC under the ticker symbol UTRS.
Minerva Surgical has 2 investors. Key investors include Accelmed, and NEA.
The ticker symbol of Minerva Surgical is UTRS on OTC.